These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1398733)

  • 1. [The role of interleukin 1 in infection and sepsis].
    Beuscher HU; Rausch UP; Röllinghoff M
    Immun Infekt; 1992 Aug; 20(4):128-33. PubMed ID: 1398733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1 and its inhibitors: a biologic and therapeutic model for the role of growth regulatory factors in leukemias.
    Kurzrock R; Wetzler M; Estrov Z; Talpaz M
    Cytokines Mol Ther; 1995 Sep; 1(3):177-84. PubMed ID: 9384674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causal links between brain cytokines and experimental febrile convulsions in the rat.
    Heida JG; Pittman QJ
    Epilepsia; 2005 Dec; 46(12):1906-13. PubMed ID: 16393156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro.
    Dinarello CA; Thompson RC
    Immunol Today; 1991 Nov; 12(11):404-10. PubMed ID: 1838480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1 and interleukin-1 receptor antagonist.
    Dinarello CA
    Nutrition; 1995; 11(5 Suppl):492-4. PubMed ID: 8748206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1.
    Dinarello CA
    Cytokine Growth Factor Rev; 1997 Dec; 8(4):253-65. PubMed ID: 9620641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular interleukin-1 receptor antagonist type 1 antagonizes the stimulatory effect of interleukin-1 alpha precursor on cell motility.
    Merhi-Soussi F; Berti M; Wehrle-Haller B; Gabay C
    Cytokine; 2005 Nov; 32(3-4):163-70. PubMed ID: 16246569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor.
    Burger D; Chicheportiche R; Giri JG; Dayer JM
    J Clin Invest; 1995 Jul; 96(1):38-41. PubMed ID: 7615809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of interleukin-1 and the therapeutic potential of interleukin-1 receptor antagonist in sepsis.
    Fisher CJ; Opal SM; Lowry SF; Sadoff JC; LaBrecque JF; Donovan HC; Lookabaugh JL; Lemke J; Pribble JP; Stromatt SC
    Circ Shock; 1994 Sep; 44(1):1-8. PubMed ID: 7704933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential gene expression for IL-1 receptor antagonist, IL-1, and TNF receptors and IL-1 and TNF synthesis may explain IL-1-induced resistance to infection.
    Vogels MT; Mensink EJ; Ye K; Boerman OC; Verschueren CM; Dinarello CA; van der Meer JW
    J Immunol; 1994 Dec; 153(12):5772-80. PubMed ID: 7989774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The balance between IL-1 and IL-1Ra in disease.
    Arend WP
    Cytokine Growth Factor Rev; 2002; 13(4-5):323-40. PubMed ID: 12220547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of interleukin-1 in host responses to infectious diseases.
    Dinarello CA
    Infect Agents Dis; 1992 Oct; 1(5):227-36. PubMed ID: 1344662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of IL-1 receptor blockade on the human response to endotoxemia.
    Van Zee KJ; Coyle SM; Calvano SE; Oldenburg HS; Stiles DM; Pribble J; Catalano M; Moldawer LL; Lowry SF
    J Immunol; 1995 Feb; 154(3):1499-507. PubMed ID: 7822813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous interleukin-1 receptor antagonist is neuroprotective.
    Loddick SA; Wong ML; Bongiorno PB; Gold PW; Licinio J; Rothwell NJ
    Biochem Biophys Res Commun; 1997 May; 234(1):211-5. PubMed ID: 9168991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of interleukin-1 beta and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits.
    Lin SJ; Yen HT; Chen YH; Ku HH; Lin FY; Chen YL
    J Cell Biochem; 2003 Mar; 88(4):836-47. PubMed ID: 12577317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis.
    Dinarello CA
    Kidney Int Suppl; 1992 Oct; 38():S68-77. PubMed ID: 1328757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 receptor antagonism.
    Nikolic-Paterson DJ; Lan HY; Atkins RC
    Semin Nephrol; 1996 Nov; 16(6):583-90. PubMed ID: 9125803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and characterization of IL-1 receptor antagonist in tissues from healthy rabbits: IL-1 receptor antagonist is probably involved in health.
    Matsukawa A; Fukumoto T; Maeda T; Ohkawara S; Yoshinaga M
    Cytokine; 1997 May; 9(5):307-15. PubMed ID: 9195129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic control of the tumor necrosis factor and interleukin-1 signaling cascade.
    Stewart RJ; Marsden PA
    Am J Kidney Dis; 1995 Jun; 25(6):954-66. PubMed ID: 7771496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [NASH model-- role of interleukin-1 receptor].
    Sawada S; Saito H; Kusuhara M
    Nihon Rinsho; 2006 Jun; 64(6):1063-70. PubMed ID: 16768110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.